Breaking News

Centogene Opening Lab to Increase COVID-19 Testing

Acquiring former laboratory facilities and equipment of Provecs Medical GmbH in Hamburg, Germany

By: Contract Pharma

Contract Pharma Staff

Centogene, a commercial-stage company focused on rare diseases, is opening a new laboratory in Hamburg, Germany—acquiring the former laboratory facilities and equipment of Provecs Medical GmbH, a company formerly active in cancer immunotherapy. The new laboratory, which is opening in April 2020, will enable increased testing capacity for the COVID-19 virus and will also result in the expansion of laboratory capacity for the company’s diagnostic testing of rare genetic diseases.   “The opening of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters